Syndrome  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
SAKK 33/99, NCT00004208: Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome

Completed
3
86
Europe
ATG + CSA, Supportive care
Swiss Group for Clinical Cancer Research
Myelodysplastic Syndromes
10/06
10/11
NCT00502073: Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-005)

Completed
3
US
cyclosporine
Sirion Therapeutics, Inc.
Dry Eye Syndromes
 
 
NCT00548301: Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)

Completed
3
US
cyclosporine
Sirion Therapeutics, Inc.
Dry Eye Syndromes
 
 
CIS001, NCT00755781: Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation

Completed
3
284
US, Canada
Cyclosporine Inhalation Solution (CIS), Cyclosporine
APT Pharmaceuticals, Inc.
Lung Transplant
09/11
11/11
NCT00938236: CIS001 Extension Study of Cyclosporine Inhalation Solution

Terminated
3
17
US, Canada
Cyclosporine Inhalation Solution (CIS)
APT Pharmaceuticals, Inc.
Lung Transplant
09/11
12/11
NCT00003187: Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Completed
2/3
19
US
filgrastim, cyclophosphamide, cyclosporine, cytarabine, methotrexate, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation, radiation therapy
Virginia Commonwealth University, National Cancer Institute (NCI)
Leukemia, Lymphoma, Myelodysplastic Syndromes
02/05
02/05

Download Options